en

PRODUCT DETAIL

Bosulif 100 mg filmom obalené tablety

Code 4973A
MA number EU/1/13/818/002
Product Form: tbl flm 30x100 mg (blis.PVC/PCTFE/PVC)
MA Status: Ex - Conditional centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EA BCR-ABL tyrosine kinase inhibitors
L01EA04 Bosutinib
Shelf life: 48
Container: blister PVC/Aclar
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 07.04.2022
Validity: 07.04.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 26.04.2022
eu-flag.png sk-flag.png